For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are ...

Ozempic and Rybelsus both treat diabetes and cause weight loss, but Ozempic is an injection and Rybelsus is a pill.

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...

Share on Pinterest New research suggests that the oral version of semaglutide, the active ingredient in injectable drugs like Ozempic, may also help treat diabetes and heart disease. Image credit: ...

Please provide your email address to receive an email when new articles are posted on . The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, ...

The FDA has approved semaglutide, a drug used to treat type 2 diabetes, for obesity management. Evidence suggests it can help people lose weight by suppressing appetite, as long as they keep taking it ...

Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) ...

One study found that semaglutide helps to improve liver health in people with metabolic dysfunction-associated steatohepatitis, a serious form of fatty liver disease. The use of semaglutide, a ...

A recent Journal of Clinical Medicine study investigates the efficacy of oral semaglutide in patients with type 2 diabetes (T2D). Study: Oral Semaglutide in Routine Clinical Practice: Characteristics ...

Treatment of people with obesity but without diabetes with the glucagon-like peptide-1 (GLP-1) agonist semaglutide (Wegovy) — hailed at its approval in 2021 as a "game changer" for the treatment of ...

SAN FRANCISCO — In patients with both type 2 diabetes and moderate chronic kidney disease (CKD), the investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Novo Nordisk) ...